Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer

NCT06841159 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Microsatellite Stable Metastatic Colorectal Cancer

Interventions

RADIATION: Ultra-fractionated radiation therapy
DRUG: Sintilimab
DRUG: Standard systemic therapy

Sponsor

Fudan University